脐血前沿 | 脐血干细胞疗法化疗缺氧缺血性脑病

对供者无危害；其肿瘤裂解分化意志力格外强，免疫原性格外低等诸多特性，使得其在上述哮喘的病患层面表现显现出了可观的药理学商业价值。我们可以预期，在不久的将来，脐血肿瘤的药理学技术的发展必将格外为广阔！

[1]Nabetani M, Shintaku H, Hamazaki T. Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy. Pediatric Research 2017. 83(1-2): 356-363.

[2]Lee ACC, Kozuki N, Blencowe H, Vos T, Bahalim A, Darmstadt GL, et al. Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatric Research 2013. 74(Suppl 1): 50-72.

[3]Matteo Bruschettini, Olga Romantsik, Alvaro Moreira, David Ley, Bernard Thébaud. Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants. Cochrane Database Syst Rev 2020. 8(8): CD013202.

[4]Verina T, Fatemi A, Johnston MV, Comi AM. Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury. Pediatric Neurology 2013. 48(5): 346-54.

[5]Tsuji M, Sawada M, Watabe S, Sano H, Kanai M, Tanaka E, etal. Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety. Scientific reports 2020. 10(1): 4603.

※ 本文转载自山东省脐血库，内容有删减

。

成都肿瘤医院预约挂号
产后私密修复
天津口腔治疗